Posts

Showing posts from August, 2026

Nepal’s Mountain Disaster: A Warning from a Warming World

Image
On 26 August 2026, a devastating flood and debris flow struck Nepal after a high-mountain failure involving ice, rock, and water. Hundreds of lives were lost and at least 1,400 people were reported missing. Investigations are continuing into the exact chain of events and the role of climatic change. But the catastrophe highlights an urgent global concern: warming is altering glaciers, snow cover, frozen ground, and water systems in mountain regions, potentially increasing vulnerability to sudden cascades of rock, ice, water, and debris. The immediate trigger may have been a particular collapse of ice, rock, saturated ground, or a temporary blockage and sudden release of water. The full sequence requires careful scientific investigation. It would be irresponsible to claim that global warming alone “caused” a single event before the evidence is complete. But the broader physical context is already well established. Warming changes the structure of high mountain landscapes. Snow cover dim...

The Pyramid of Longevity Needs a Human Summit

Image
The National Longevity Clinic’s “Pyramid of Longevity” offers a welcome corrective to one of the central distortions of today’s longevity culture. At a time when social media and commercial medicine often spotlight peptide stacks, NAD ^+ precursors, biological-age tests, continuous glucose monitors, and expensive scans, the article restores a much-needed order of priorities. Its central message is both simple and scientifically sensible: build from the base upward. Regular movement, nutritious food, restorative sleep, avoidance of tobacco, restrained alcohol use, stress regulation, and meaningful social connection matter far more than the latest supplement or fashionable biomarker panel. Medications have an important place when they address real, measurable risks. Supplements may be useful when they correct genuine deficiencies. Advanced technologies can refine a plan. But none can replace the foundation. This is an important public-health message because modern longevity marketing oft...

Clinical Presentation and Diagnosis of Orthostatic Hypotension

Image
Orthostatic hypotension (Orthostatic Arterial Hypotension) is a common yet underdiagnosed condition marked by a fall in blood pressure upon standing. Recognizing the wide range of clinical presentations and using appropriate diagnostic tools is essential to avoid missed or delayed diagnosis. This chapter outlines the typical and atypical symptoms of Orthostatic Arterial Hypotension, discusses the nuances of bedside and specialized testing, and reviews how to differentiate Orthostatic Arterial Hypotension from other causes of dizziness and syncope. Clinical Presentation Symptoms of Orthostatic Arterial Hypotension are closely tied to postural changes and typically improve or resolve when the patient sits or lies down. Common triggers include rising in the morning, moving from sitting to standing, and prolonged standing, particularly in hot environments or after meals. Common symptoms include: Lightheadedness or presyncope Dizziness or vertigo Transient loss of consciousness Falls Blurre...

Coconut Oil vs. Other Oils for Skin Care: Where Each One Actually Wins

Image
Coconut oil has graduated from folk remedy to something dermatology can point to real trial data for. But "evidence-backed" doesn't mean "best in every situation." When patients ask their doctors whether to reach for coconut oil, mineral oil, petroleum jelly, olive oil, or sunflower seed oil — or a blend of several — the honest answer is that each has a different niche, and one popular choice, olive oil, may do more harm than good on compromised skin. Where Coconut Oil Should Be the First Choice Pediatric atopic dermatitis maintenance. In a randomized, double-blind trial of 117 children with mild-to-moderate atopic dermatitis, eight weeks of topical virgin coconut oil beat mineral oil on SCORAD severity scores, transepidermal water loss, and skin capacitance. A separate review of atopic dermatitis studies confirmed coconut oil outperformed mineral oil among the oils examined.  Situations where antimicrobial activity matters. Roughly half of virgin coconut oil...

How to Escape (or at Least Dial Down) the Social‑Media "Maxxing" Trap

Image
Jennifer Donnelly's recent piece for The Conversation US turned attention to something worth taking seriously: the growing habit of "maxxing" everything — looks, fiber, personality, productivity — as if self‑improvement were a video game with a maximum score to hit. Her core observation is that pushing any trait toward its theoretical limit can quietly convert healthy self‑improvement into a source of stress, comparison, and self‑criticism rather than well‑being. That observation is the starting point for this piece — and underneath it lies a deeper, more rigorous principle that both "maxxing" culture and the usual critiques of it tend to miss: the goal is not a maximum. It is the golden middle.  The Real Target Is the Center, Not Either Edge The clearest way to see the flaw in "maxxing" logic comes from basic physiology, specifically the principle of symmetry in health, described in the book   Symmetry in health and illness . Its central argument ref...

Beyond Average Effects: A Practical Framework for Tails, Treatment Heterogeneity, and Clinical Decision-Making

Image
M. Iabluchanskyi, A Martynenko, V. Shlyakhover, G. Raimondi, A. Yabluchanskiy Abstract Clinical trials are commonly summarized by a single average treatment effect, expressed as a mean difference, relative risk, odds ratio, hazard ratio, or median outcome. These measures are indispensable for population-level inference, but they may not fully describe the clinical reality of treatment. An apparently favorable average can coexist with profound nonresponse, clinically important deterioration, severe toxicity, rare catastrophic harm, extreme vulnerability, and, in some cases, exceptional benefit. Such clinically consequential information may be concentrated in the lower and upper tails of outcome distributions. Existing methodological and regulatory guidance already addresses important components of this problem, including harms reporting, estimands, sensitivity analysis, prespecified subgroup analysis, enrichment, quality by design, and postmarketing surveillance. This article synthesize...